|Tested species reactivity||Non-human primate, Rat|
|Published species reactivity||Rat|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Activated, Lewis rat derived microglial cells|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Flow Cytometry (Flow)||1:50-1:100|
|Immunofluorescence (IF)||Assay Dependent|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 1 publications below|
This product is a low-endotoxin, preservative-free formulation. Endotoxin level is <0.01 EU/ug.
For FACS analysis, use 10ul of the suggested working dilution to label 1x10^6 cells in 100ul.
cell adhesion molecule, also intracellular signaling molecule; may mediate leukocyte adhesion and migration, angiogenesis, and thrombosis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Erythropoietin protects against doxorubicin-induced heart failure.
MA5-16951 was used in immunohistochemistry to study the ability of erythropoeitin to protect against heart failure induced by treatment with the cancer drug doxorubicin
|Ammar HI,Saba S,Ammar RI,Elsayed LA,Ghaly WB,Dhingra S||American journal of physiology. Heart and circulatory physiology (301:H2413)||2011|